Sale to a Consortium Led by AGIC Capital

Healthcare
Sale to a Consortium Led by AGIC Capital

Summary

Baird served as a financial advisor to The Ritedose Corporation on this transaction

About

The Ritedose Corporation (“Ritedose” or the “Company”), a portfolio company of Olympus Partners (“Olympus”), was recently acquired by a consortium led by AGIC Capital (“AGIC”). Terms of the transaction have not been disclosed.

Ritedose is a pharmaceutical company specializing in inhalation and ophthalmic drugs. The Company is the industry leader in Blow-Fill-Seal technology, a manufacturing process by which a container is formed, filled and sealed in a continuous process inside a sterile, enclosed machine. The Company also conducts research and development activities aimed at product development and process improvement. Ritedose is headquartered in Columbia, South Carolina.

Founded in 1988, Olympus Partners is a private equity firm focused on providing equity capital for management buyouts and for companies needing capital for expansion. Olympus is an active, long-term investor across a broad range of industries, including restaurants, consumer products, healthcare services, financial services and business services. Olympus manages in excess of $5.5 billion primarily on behalf of corporate pension funds, endowment funds and state-sponsored retirement programs. Olympus is headquartered in Stamford, Connecticut.

AGIC Capital is a European-Asian private equity fund, which focuses on investing in fast growing companies in Europe and the United States. Investment opportunities are focused on five industry sectors: intelligent production, high-end systems and components, advanced materials, medical equipment and environmental protection technologies. AGIC supports its portfolio companies in the execution of their buy-and-build strategies, organic growth initiatives and operating improvements. AGIC strongly supports the concept of investing with a business purpose and working closely with the top management of its companies. AGIC closed Fund I, its debut fund, in December 2016 with $1 billion successfully raised. AGIC is headquartered in Hong Kong, China.
CONTACT US TO LEARN MORE
Healthcare
Sale to a Consortium Led by AGIC Capital
Date
September 2017
Company
The Ritedose Corporation
Transaction
M&A
Sectors
Healthcare
Target Location
North America
Acquiror Location
Asia

Share